The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Work loss and activity impairment due to duration of nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.
 
Lee S. Schwartzberg
Stock and Other Ownership Interests - Vector Oncology
Honoraria - Amgen; AstraZeneca; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Healthcare; Myriad Genetics; NanoString Technologies; Napo Pharmaceuticals; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Athenex; Biocept; bioTheranostics; Bristol-Myers Squibb; Caris Life Sciences; Coherus Biosciences; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Therapeutics; Lilly; Merck; Novartis; Pfizer; Roche; Spectrum Pharmaceuticals; Tesaro
Speakers' Bureau - Coherus Biosciences; Puma Biotechnology
Research Funding - Amgen (Inst); Bayer Health (Inst); E.R. Squibb Sons, LLC (Inst); E.R. Squibb Sons, LLC (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics; MedImmune (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)
 
Rudolph M. Navari
Honoraria - HERON
Research Funding - HERON (Inst)
Travel, Accommodations, Expenses - HERON
 
Kathryn Jean Ruddy
Stock and Other Ownership Interests - Merck; Pfizer
Patents, Royalties, Other Intellectual Property - My husband is a co-inventor of technology licensed by Mayo Clinic to AliveCor (MountainView, CA), which makes a smartphone-enabled remote ECG monitoring system. (I)
 
Thomas William LeBlanc
Honoraria - Celgene; Daiichi Sankyo; Quintiles
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Heron; Otsuka; Pfizer; Seagen
Speakers' Bureau - Agios; Celgene
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Amgen; Celgene; Daiichi Sankyo; Heron; Otsuka
 
Rebecca Anne Clark-Snow
Consulting or Advisory Role - Helsinn Therapeutics; Heron
Speakers' Bureau - Merck
 
Rita S. Wickham
Honoraria - Genentech/Roche; Insys Therapeutics
Consulting or Advisory Role - Helsinn Healthcare; Insys Therapeutics
Speakers' Bureau - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Abbvie; Helsinn Healthcare; Insys Therapeutics
 
Gary Binder
Employment - Helsinn Therapeutics
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Helsinn Therapeutics
 
William Bailey
Employment - Helsinn Therapeutics
 
Marco Turini
Employment - Helsinn Healthcare
 
Ravi C. Potluri
Employment - SmartAnalyst
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Helsinn Therapeutics (Inst); Janssen (Inst)
 
Luke M. Schmerold
Employment - SmartAnalyst
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Helsinn Therapeutics (Inst); Janssen (Inst)
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; Asahi Kasei; BASF; Helsinn Healthcare (Inst); HERON; Immuneering; Napo Pharmaceuticals; Oragenics; Oragenics; Pfizer/EMD Serono; Vector Oncology